The complexity of IGFBP-3 actions on breast cancer cells has long been acknowledged with reports of opposite effects and with the surrounding extracellular matrix microenvironment [15] and changes in the sphingolipid rheostat [28] having been described as underlying these different actions. This evidence concerns the gene IGFBP3 and breast carcinoma.